Haverford Trust Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.48M | Sell |
40,901
-3,583
| -8% | -$209K | 0.02% | 165 |
|
|
2025
Q4 | $2.4M | Sell |
44,484
-3,093
| -7% | -$149K | 0.02% | 164 |
|
|
2025
Q3 | $2.15M | Sell |
47,577
-4,785
| -9% | -$223K | 0.02% | 165 |
|
|
2025
Q2 | $2.42M | Sell |
52,362
-1,050
| -2% | -$51.5K | 0.02% | 168 |
|
|
2025
Q1 | $3.26M | Sell |
53,412
-13,292
| -20% | -$775K | 0.03% | 145 |
|
|
2024
Q4 | $3.77M | Sell |
66,704
-525
| -0.8% | -$29.3K | 0.04% | 133 |
|
|
2024
Q3 | $3.48M | Buy |
67,229
+382
| +0.6% | +$17.9K | 0.03% | 141 |
|
|
2024
Q2 | $2.78M | Sell |
66,847
-4,869
| -7% | -$218K | 0.03% | 154 |
|
|
2024
Q1 | $3.89M | Sell |
71,716
-6,525
| -8% | -$332K | 0.04% | 135 |
|
|
2023
Q4 | $4.01M | Buy |
78,241
+1,518
| +2% | +$79.7K | 0.04% | 120 |
|
|
2023
Q3 | $4.45M | Sell |
76,723
-6,134
| -7% | -$376K | 0.05% | 110 |
|
|
2023
Q2 | $5.3M | Sell |
82,857
-1,458
| -2% | -$97.8K | 0.06% | 106 |
|
|
2023
Q1 | $5.84M | Sell |
84,315
-308
| -0.4% | -$21.7K | 0.07% | 99 |
|
|
2022
Q4 | $6.09M | Sell |
84,623
-3,009
| -3% | -$227K | 0.08% | 96 |
|
|
2022
Q3 | $6.23M | Sell |
87,632
-3,324
| -4% | -$241K | 0.09% | 96 |
|
|
2022
Q2 | $7M | Buy |
90,956
+547
| +0.6% | +$41.7K | 0.09% | 93 |
|
|
2022
Q1 | $6.6M | Buy |
90,409
+7,231
| +9% | +$486K | 0.08% | 102 |
|
|
2021
Q4 | $5.19M | Sell |
83,178
-2,292
| -3% | -$134K | 0.06% | 110 |
|
|
2021
Q3 | $5.06M | Sell |
85,470
-992
| -1% | -$65.3K | 0.06% | 108 |
|
|
2021
Q2 | $5.78M | Buy |
86,462
+3,677
| +4% | +$240K | 0.07% | 107 |
|
|
2021
Q1 | $5.23M | Sell |
82,785
-3,153
| -4% | -$196K | 0.07% | 100 |
|
|
2020
Q4 | $5.33M | Buy |
85,938
+5,287
| +7% | +$325K | 0.08% | 88 |
|
|
2020
Q3 | $4.86M | Buy |
80,651
+888
| +1% | +$53.4K | 0.08% | 86 |
|
|
2020
Q2 | $4.69M | Sell |
79,763
-2,159
| -3% | -$129K | 0.08% | 83 |
|
|
2020
Q1 | $4.57M | Buy |
81,922
+821
| +1% | +$50.2K | 0.09% | 84 |
|
|
2019
Q4 | $5.21M | Buy |
81,101
+5,678
| +8% | +$325K | 0.08% | 90 |
|
|
2019
Q3 | $3.83M | Sell |
75,423
-2,355
| -3% | -$111K | 0.07% | 91 |
|
|
2019
Q2 | $3.53M | Buy |
77,778
+31
| +0% | +$1.44K | 0.06% | 92 |
|
|
2019
Q1 | $3.71M | Buy |
77,747
+1,574
| +2% | +$78.4K | 0.07% | 89 |
|
|
2018
Q4 | $3.96M | Sell |
76,173
-4,129
| -5% | -$222K | 0.08% | 88 |
|
|
2018
Q3 | $4.99M | Sell |
80,302
-1,242
| -2% | -$73.7K | 0.09% | 86 |
|
|
2018
Q2 | $4.51M | Sell |
81,544
-5,069
| -6% | -$274K | 0.09% | 87 |
|
|
2018
Q1 | $5.48M | Buy |
86,613
+4,313
| +5% | +$277K | 0.11% | 81 |
|
|
2017
Q4 | $5.04M | Buy |
82,300
+4,068
| +5% | +$254K | 0.1% | 79 |
|
|
2017
Q3 | $4.99M | Buy |
78,232
+2,760
| +4% | +$161K | 0.1% | 75 |
|
|
2017
Q2 | $4.21M | Buy |
75,472
+191
| +0.3% | +$10.4K | 0.09% | 78 |
|
|
2017
Q1 | $4.09M | Sell |
75,281
-1,813
| -2% | -$99.4K | 0.09% | 78 |
|
|
2016
Q4 | $4.5M | Buy |
77,094
+397
| +0.5% | +$21.7K | 0.11% | 74 |
|
|
2016
Q3 | $4.14M | Buy |
76,697
+813
| +1% | +$52.2K | 0.1% | 77 |
|
|
2016
Q2 | $5.58M | Buy |
75,884
+5,453
| +8% | +$385K | 0.14% | 73 |
|
|
2016
Q1 | $4.5M | Sell |
70,431
-135
| -0.2% | -$8.51K | 0.12% | 75 |
|
|
2015
Q4 | $4.85M | Sell |
70,566
-2,999
| -4% | -$198K | 0.13% | 74 |
|
|
2015
Q3 | $4.36M | Buy |
73,565
+7,114
| +11% | +$451K | 0.13% | 70 |
|
|
2015
Q2 | $4.42M | Sell |
66,451
-107
| -0.2% | -$7.05K | 0.12% | 72 |
|
|
2015
Q1 | $4.29M | Sell |
66,558
-433
| -0.6% | -$27.1K | 0.12% | 78 |
|
|
2014
Q4 | $3.95M | Sell |
66,991
-358
| -0.5% | -$20.2K | 0.11% | 83 |
|
|
2014
Q3 | $3.45M | Buy |
67,349
+430
| +0.6% | +$21.5K | 0.1% | 80 |
|
|
2014
Q2 | $3.25M | Buy |
66,919
+2,850
| +4% | +$140K | 0.1% | 79 |
|
|
2014
Q1 | $3.33M | Sell |
64,069
-82,162
| -56% | -$4.37M | 0.1% | 77 |
|
|
2013
Q4 | $7.77M | Buy |
146,231
+42
| +0% | +$2.14K | 0.22% | 71 |
|
|
2013
Q3 | $6.77M | Buy |
146,189
+15,696
| +12% | +$689K | 0.25% | 58 |
|
|
2013
Q2 | $5.83M | Buy |
+130,493
| New | +$5.67M | 0.19% | 70 |
|
Other funds holding BMY
VCM
VPM
Haverford Trust Company's BMY Position: Q1 2026 in Review
Haverford Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 8.1% in Q1 2026, selling an estimated $209K and leaving 40,901 shares worth $2.48M. The position accounts for 0.02% of the portfolio, ranked #165.
Haverford Trust Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.77M in Q4 2013. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Haverford Trust Company held 40,901 shares of Bristol-Myers Squibb worth $2.48M as of Q1 2026.
- Haverford Trust Company sold 3,583 Bristol-Myers Squibb shares in Q1 2026, an estimated $209K.
- Bristol-Myers Squibb made up 0.02% of Haverford Trust Company's portfolio in Q1 2026, its #165 holding.
- Haverford Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Haverford Trust Company's Bristol-Myers Squibb position peaked at $7.77M in Q4 2013.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.